June 2020 - Page 279 of 383

NYSE Companies - June 8, 2020

O-I Glass Second Quarter 2020 Business Update

PERRYSBURG, Ohio, June 08, 2020 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI) today provided a business update in advance […]

NASDAQ Companies - June 8, 2020

Replimune Announces Proposed Public Offering

BOSTON, June 08, 2020 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived […]

NASDAQ Companies - June 8, 2020

Predictive Oncology Reports First Quarter 2020 Financial Results, Provides Business Update

NEW YORK, June 08, 2020 (GLOBE NEWSWIRE) — Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence […]

NASDAQ Companies - June 8, 2020

Monroe Capital Corporation BDC Announces Change of 2020 Annual Meeting of Stockholders to Virtual Format

CHICAGO, June 08, 2020 (GLOBE NEWSWIRE) — Monroe Capital Corporation (Nasdaq: MRCC) (“Monroe”) announced today that, due to the COVID-19 […]

NYSE Companies - June 8, 2020

Oil-Dri Announces Third Quarter and First Nine-Months of Fiscal 2020 Results

CHICAGO, June 08, 2020 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, […]

NASDAQ Companies - June 8, 2020

Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital

GAITHERSBURG, Md., June 08, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for […]

NASDAQ Companies - June 8, 2020

GBT Announces Plans to Seek Expanded Labeling for Oxbryta® (voxelotor) to Treat Children Ages 4 to 11 Years with Sickle Cell Disease

New Drug Application submission, including new age-appropriate formulation, planned by mid-2021SOUTH SAN FRANCISCO, Calif., June 08, 2020 (GLOBE NEWSWIRE) — […]